Evidence map›Paper›PMID 36699015›Full record

ReviewFrontiers in cell and developmental biology2022

Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine.

Giuseppe Novelli, Paola Spitalieri, Michela Murdocca, Eleonora Centanini, Federica Sangiuolo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Giuseppe NovelliDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Paola SpitalieriDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Michela MurdoccaDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Eleonora CentaniniDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende, CS, Italy.
Federica SangiuoloDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the last decades, hiPSC-derived organoids have been extensively studied and used as

Indexed as

disease modeling.human induced pluripotent stem cell (hiPSC)organoid factoryorganoids manufacturingprecision medicine

Identifiers

PMID36699015
PMCPMC9869172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.